| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Greenberg Arthur is a Director at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $244K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2016 | GALT Galectin Therapeutics Inc | Director | Buy | 1,666 | $1.72 | $2,865.52 | +1.5% |